Be part of our team
As a highly skilled and detail-oriented Clinical Operations Inspection Lead you will oversee and manage preparations for inspection activities across our global clinical trials. The ideal candidate will ensure compliance with regulatory requirements, Good Clinical Practice (GCP), and internal standards while leading inspection readiness initiatives. This role requires strong leadership, excellent analytical skills, and the ability to collaborate effectively across cross-functional teams.
This position is available in the Boston metro region as well as the following remote locations: MA, NY, PA, RI, NJ, MD, NC, and FL. Please only apply if you are located in one of these states.
Why us?
At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.
- Impact that matters: Contribute to breakthrough therapies.
- Global mindset: Work in an international, diverse team.
- Grow & thrive: Develop your career in a supportive, fast-moving environment.
- Innovation every day: Push boundaries with cutting-edge science.
At Tubulis, your ideas matter, your growth matters—and together, we make a difference.
About us
Tubulis is a clinical stage biotech company that generates uniquely matched antibody-drug conjugates (ADCs) with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activity in preclinical models. We recently closed on a Series C fundraising round totaling €344M (US $401M).
The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and ADCs. With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.
